Medicines supply agreement for Alectinib

Summary

The tender concerns a medicines supply/open-house discount agreement for the active substance Alectinib. The participating health insurers aim to conclude discount agreements with all suitable pharmaceutical companies under uniform conditions, with no individual negotiations and no exclusivity. The contract term for TK is up to 24 months from 01.08.2026 and ends no later than 31.07.2028; accession is possible at any time during the term. Further participation and contract details must be checked in the tender documents.